Using blood flow restriction therapy for Achilles injuries
Blood Flow Restriction Therapy in Achilles Injury
This study tests whether combining blood flow restriction therapy with regular physical therapy can help people recover better from Achilles injuries.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 57 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT04104126 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of blood flow restriction (BFR) therapy combined with standard physical therapy on patients recovering from Achilles injuries. BFR therapy involves a brief and partial restriction of venous outflow during low-load resistance exercises, aiming to enhance strength and rehabilitation outcomes. The study is prospective and randomized, focusing on how this innovative treatment approach can improve recovery for individuals diagnosed with Achilles injuries.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have been diagnosed with an Achilles injury and intend to receive physical therapy.
Not a fit: Patients with severe hypertension, impaired circulation, or those outside the age range of 18 to 65 may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance rehabilitation outcomes for patients with Achilles injuries.
How similar studies have performed: Previous studies have shown promising results with blood flow restriction therapy in various rehabilitation contexts, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with Achilles Injury * Must be at least 18 years of age and younger than 65 years of age * Intention to receive physical therapy as standard of care Exclusion Criteria: * Patients with intention to receive standard therapy and not the study therapy * Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension * Younger than 18 years of age or older than 65 * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.) * Any patient considered a vulnerable subject
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Guillem Gonzalez-Lomas, MD — New York Langone Health
- Study coordinator: Larry Chen
- Email: Larry.Chen@nyulangone.org
- Phone: (317)847-1784
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.